Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-DAMP is a **selective muscarinic acetylcholine receptor antagonist** that shows **highest affinity for the M3 receptor subtype** but can also antagonize other muscarinic receptor subtypes, including M1, M2, M4, and M5, with markedly lower potency at M2 than M3. It acts as a competitive antagonist at the acetylcholine binding site, inhibiting downstream cholinergic signaling. 4-DAMP is a quaternary ammonium compound and is used widely in pharmacological research to delineate the roles of muscarinic receptor subtypes in various tissues[^1][1][2][9][11][14][15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-DAMP.